SKI Market

Indian Indices

Nifty

25,910.05 30.90
(0.12%)

Sensex

84,562.78 84.11
( 0.10%)

Bank Nifty

58,517.55 135.60
( 0.23%)

Nifty IT

36,301.25 -378.20
( -1.03%)

Global Indices

Nasdaq

47,163.83 -314.39
(-0.66%)

Dow Jones

6,754.35 -4.14
(-0.06%)

Hang Seng

50,333.56 -948.27
(-1.85%)

Nikkei 225

9,693.83 -113.85
(-1.16%)

Forex

USD-INR

88.71 0.12
(0.13%)

EUR-INR

103.04 0.44
(0.43%)

GBP-INR

116.72 0.41
(0.35%)

JPY-INR

0.57 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

30.5295026

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

42.73

8732.47

EPS(TTM)

Face Value()

Div & Yield %

4.51

0.42

Back

Nyssa Corporation consolidated net profit declines 62.23% in the June 2025 quarter

Aug 15,2025

Net profit of Nyssa Corporation declined 62.23% to Rs 0.71 crore in the quarter ended June 2025 as against Rs 1.88 crore during the previous quarter ended June 2024. Sales declined 51.86% to Rs 1.42 crore in the quarter ended June 2025 as against Rs 2.95 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	1.42	2.95	-52
OPM %	60.56	80.00	-
PBDT	0.96	2.51	-62
PBT	0.96	2.51	-62
NP	0.71	1.88	-62

25,910.05 30.90 (0.12%)

84,562.78 84.11 ( 0.10%)

58,517.55 135.60 ( 0.23%)

36,301.25 -378.20 ( -1.03%)

47,163.83 -314.39 (-0.66%)

6,754.35 -4.14 (-0.06%)

50,333.56 -948.27 (-1.85%)

9,693.83 -113.85 (-1.16%)

88.71 0.12 (0.13%)

103.04 0.44 (0.43%)

116.72 0.41 (0.35%)

0.57 0.00 (0.16%)